Oxford Cannabinoid Technologies Investor Relations Material
Latest events
H2 2024
24 Nov, 2024
H1 2023
29 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxford Cannabinoid Technologies Holdings PLC
Access all reports
Oxford Cannabinoid Technologies Holdings PLC is a UK-based pharmaceutical company focused on developing prescription cannabinoid-based therapies. The company targets conditions including chronic pain and neurological disorders, advancing its drug candidates through preclinical and clinical development phases. It operates within a regulated scientific framework and collaborates with academic partners. The company is headquartered in London, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
OCTH
Country
🇬🇧 United Kingdom